Title:
FUSION FORMED AND ION EXCHANGED GLASS-CERAMICS
Document Type and Number:
WIPO Patent Application WO/2012/075068
Kind Code:
A3
Abstract:
The present disclosure relates to fusion formable highly crystalline glass-ceramic articles whose composition lies within the SiO2--R2O3--Li2O/Na2O--TiO2 system and which contain a silicate crystalline phase comprised of lithium aluminosilicate (β-spodumene and/or β-quartz solid solution) lithium metasilicate and/or lithium disilicate. Additionally, these silicate-crystal containing glass-ceramics can exhibit varying Na2O to Li2O molar ratio extending from the surface to the bulk of the glass article, particularly a decreasing Li2O concentration and an increasing Na2O concentration from surface to bulk. According to a second embodiment, disclosed herein is a method for forming a silicate crystalline phase-containing glass ceramic.
Inventors:
BEALL GEORGE HALSEY (US)
BORRELLI NICHOLAS FRANCIS (US)
SMITH CHARLENE MARIE (US)
TIETJE STEVEN ALVIN (US)
BORRELLI NICHOLAS FRANCIS (US)
SMITH CHARLENE MARIE (US)
TIETJE STEVEN ALVIN (US)
Application Number:
PCT/US2011/062515
Publication Date:
July 19, 2012
Filing Date:
November 30, 2011
Export Citation:
Assignee:
CORNING INC (US)
BEALL GEORGE HALSEY (US)
BORRELLI NICHOLAS FRANCIS (US)
SMITH CHARLENE MARIE (US)
TIETJE STEVEN ALVIN (US)
BEALL GEORGE HALSEY (US)
BORRELLI NICHOLAS FRANCIS (US)
SMITH CHARLENE MARIE (US)
TIETJE STEVEN ALVIN (US)
International Classes:
C03C3/093; C03C3/083; C03C3/085; C03C3/091; C03C10/00; C03C21/00
Foreign References:
US4755488A | 1988-07-05 | |||
FR2132269A1 | 1972-11-17 | |||
US20090162608A1 | 2009-06-25 | |||
US3282770A | 1966-11-01 | |||
US4059454A | 1977-11-22 | |||
US4042403A | 1977-08-16 | |||
US3812689A | 1974-05-28 |
Attorney, Agent or Firm:
SCHAEBERLE, Timothy M. (Intellectual Property DepartmentSP-Ti-03-0, Corning New York, US)
Download PDF:
Previous Patent: CUTTING GUIDE
Next Patent: SIGNATURES AND DETERMINANTS ASSOCIATED WITH CANCER AND METHODS OF USE THEREOF
Next Patent: SIGNATURES AND DETERMINANTS ASSOCIATED WITH CANCER AND METHODS OF USE THEREOF